Latest News about REGN
Recent news which mentions REGN
3 Stocks to Buy to Ride Europe’s Coming Market Surge
September 19, 2023
From InvestorPlace
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
September 18, 2023
Tickers
REGN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
September 15, 2023
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
September 14, 2023
Tickers
REGN
From Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Morgan Stanley says it’s a lonely bull, recommending government bonds
September 11, 2023
From MarketWatch
New to Investing? Here's How You Can Get Started With $500.
September 10, 2023
From Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
September 09, 2023
From Motley Fool
2 Top Biotech Stocks to Buy in September
September 08, 2023
From Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,000 Today
September 05, 2023
Tickers
REGN
From Benzinga
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
September 05, 2023
From Motley Fool
10 growth stocks that are trading at bargain prices, including Delta and Cheniere Energy
August 30, 2023
From MarketWatch
Small Cancer Therapy Player Celularity To Provide Research Support For Regeneron's Therapy
August 29, 2023
From Benzinga
Wall Street Thinks This Tiny Biotech Company Could Soar Soon
August 28, 2023
From Motley Fool
These Are the ONLY 7 Penny Stocks to Consider in August 2023
August 26, 2023
From InvestorPlace
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
From Motley Fool
Top 5 Health Care Stocks That May Fall Off A Cliff
August 23, 2023
From Benzinga
Regeneron Awarded $326M Government Contract For COVID-19 Antibody Therapy Development
August 22, 2023
Tickers
REGN
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
August 22, 2023
Tickers
REGN
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
From Benzinga
Value Stocks Outshine Growth Amidst Rising Treasury Yields: Key Sectors and Stocks Analyzed
August 21, 2023
From Benzinga
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
Tickers
REGN
From Benzinga
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
From Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
From Motley Fool
18 Analysts Have This to Say About Regeneron Pharmaceuticals
August 16, 2023
Tickers
REGN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.